{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T18:02:23Z","timestamp":1761156143043},"reference-count":36,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["redjournal.org","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.ijrobp.2016.07.004","type":"journal-article","created":{"date-parts":[[2016,7,16]],"date-time":"2016-07-16T20:44:55Z","timestamp":1468701895000},"page":"606-613","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Simultaneous Integrated Boost Volumetric Modulated Arc Therapy in the Postoperative Treatment of High-Risk to Intermediate-Risk Endometrial Cancer: Results of ADA II Phase 1-2 Trial"],"prefix":"10.1016","volume":"96","author":[{"given":"Gabriella","family":"Macchia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Savino","family":"Cilla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Deodato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Ianiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Legge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martina","family":"Marucci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Cammelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna Myriam","family":"Perrone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierandrea","family":"De Iaco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Antonietta","family":"Gambacorta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosa","family":"Autorino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincenzo","family":"Valentini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessio G.","family":"Morganti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriella","family":"Ferrandina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2016.07.004_bib1","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1158\/1055-9965.EPI-14-0923","article-title":"Metabolic syndrome and risk of endometrial cancer in the United States: A study in the SEER-Medicare linked database","volume":"24","author":"Trabert","year":"2015","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.ijrobp.2016.07.004_bib2","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.2217\/fon.14.192","article-title":"USA endometrial cancer projections to 2030: Should we be concerned?","volume":"10","author":"Sheikh","year":"2014","journal-title":"Future Oncol"},{"key":"10.1016\/j.ijrobp.2016.07.004_bib3","first-page":"1531","article-title":"Obesity, endogenous hormones, and endometrial cancer risk: A synthetic review","volume":"11","author":"Kaaks","year":"2002","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.ijrobp.2016.07.004_bib4","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S0140-6736(08)60269-X","article-title":"Body-mass index and incidence of cancer: A systematic review and meta-analysis of prospective observational studies","volume":"371","author":"Renehan","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.ijrobp.2016.07.004_bib5","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/S0140-6736(15)00130-0","article-title":"Endometrial cancer","volume":"387","author":"Morice","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.ijrobp.2016.07.004_bib6","series-title":"NCCN Clinical Practice Guidelines in Oncology (NCCNGuidelines). Uterine Neoplasms Version 3","year":"2012"},{"key":"10.1016\/j.ijrobp.2016.07.004_bib7","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.prro.2014.01.003","article-title":"The role of postoperative radiation therapy for endometrial cancer: Executive Summary of an American Society for Radiation Oncology evidence-based guideline","volume":"4","author":"Klopp","year":"2014","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2016.07.004_bib8","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.ijrobp.2015.08.023","article-title":"Long-term impact of endometrial cancer diagnosis and treatment on health-related quality of life and cancer survivorship: Results from the randomized PORTEC-2 trial","volume":"93","author":"de Boer","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2016.07.004_bib9","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1097\/IGC.0b013e31828b15cb","article-title":"Adjuvant radiation therapy for patients with type II endometrial carcinoma: Impact on tumor recurrence and survival","volume":"23","author":"Yechieli","year":"2013","journal-title":"Int J Gynecol Cancer"},{"issue":"3","key":"10.1016\/j.ijrobp.2016.07.004_bib10","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.ygyno.2010.11.021","article-title":"3D conformal postoperative radiotherapy with concomitant boost in uterine cancer: results of a phase I-II study (ADA-RT-1)","volume":"120","author":"Macchia","year":"2011","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ijrobp.2016.07.004_bib11","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.radonc.2006.04.014","article-title":"Factors influencing bowel sparing in intensity modulated whole pelvic radiotherapy for gynaecological malignancies","volume":"80","author":"Georg","year":"2006","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2016.07.004_bib12","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0360-3016(01)01664-9","article-title":"Intensity modulated radiation therapy (IMRT) reduces small bowel, rectum and bladder doses in patients with cervical cancer receiving pelvic and para-aortic irradiation","volume":"51","author":"Portelance","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2016.07.004_bib13","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.ijrobp.2004.06.253","article-title":"Intensity modulated arc therapy for treatment of high risk endometrial malignancies","volume":"61","author":"Wong","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2016.07.004_bib14","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1016\/S0360-3016(01)02785-7","article-title":"Intensity modulated whole pelvic radiotherapy in women with gynaecologic malignancies","volume":"52","author":"Mundt","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2016.07.004_bib15","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1016\/S0360-3016(00)00771-9","article-title":"Intensity modulated whole pelvic radiation therapy in patients with gynecologic malignancies","volume":"48","author":"Roeske","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.ijrobp.2016.07.004_bib16","doi-asserted-by":"crossref","first-page":"251","DOI":"10.3109\/0284186X.2013.819997","article-title":"Adjuvant volumetric-modulated arc therapy with simultaneous integrated boost in endometrial cancer. Planning and toxicity comparison","volume":"53","author":"Macchia","year":"2014","journal-title":"Acta Oncol"},{"key":"10.1016\/j.ijrobp.2016.07.004_bib17","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.clon.2011.07.001","article-title":"Volumetric modulated arc therapy with simultaneous integrated boost for locally advanced rectal cancer","volume":"24","author":"Cilla","year":"2012","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.ijrobp.2016.07.004_bib18","doi-asserted-by":"crossref","first-page":"20150832","DOI":"10.1259\/bjr.20150832","article-title":"Volumetric modulated arc therapy (VMAT) in the combined modality treatment of anal cancer patients","volume":"89","author":"Franco","year":"2016","journal-title":"Br J Radiol"},{"key":"10.1016\/j.ijrobp.2016.07.004_bib19","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.ijrobp.2009.03.029","article-title":"Whole-brain radiotherapy with simultaneous integrated boost to multiple brain metastases using volumetric modulated arc therapy","volume":"75","author":"Lagerwaard","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2016.07.004_bib20","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/1748-717X-5-54","article-title":"Early clinical experience of radiotherapy of prostate cancer with volumetric modulated arc therapy","volume":"5","author":"Pesce","year":"2010","journal-title":"Radiat Oncol"},{"issue":"1","key":"10.1016\/j.ijrobp.2016.07.004_bib21","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.meddos.2012.04.004","article-title":"Applicator-guided volumetric-modulated arc therapy for low-risk endometrial cancer","volume":"38","author":"Cilla","year":"2013","journal-title":"Med Dosim"},{"key":"10.1016\/j.ijrobp.2016.07.004_bib22","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.meddos.2013.04.001","article-title":"Feasibility study of volumetric modulated arc therapy with constant dose rate for endometrial cancer","volume":"38","author":"Yang","year":"2013","journal-title":"Med Dosim"},{"key":"10.1016\/j.ijrobp.2016.07.004_bib23","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1186\/1471-2407-13-515","article-title":"SmartArc-based volumetric modulated arc therapy for endometrial cancer: A dosimetric comparison with helical tomotherapy and intensity-modulated radiation therapy","volume":"13","author":"Yang","year":"2013","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ijrobp.2016.07.004_bib24","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/1748-717X-9-153","article-title":"A treatment planning study comparing Elekta VMAT and fixed field IMRT using the Varian treatment planning system Eclipse","volume":"9","author":"Peters","year":"2014","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2016.07.004_bib25","first-page":"2149","article-title":"Volumetric-modulated arc therapy with vaginal cuff simultaneous integrated boost as an alternative to brachytherapy in adjuvant irradiation for endometrial cancer: A prospective study","volume":"35","author":"Alongi","year":"2015","journal-title":"Anticancer Res"},{"key":"10.1016\/j.ijrobp.2016.07.004_bib26","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0167-8140(83)80021-8","article-title":"A new isoeffect curve for change in dose per fraction","volume":"1","author":"Withers","year":"1983","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2016.07.004_bib27","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.radonc.2014.01.018","article-title":"Impact of postoperative intensity modulated radiotherapy on acute gastro-intestinal toxicity for patients with endometrial cancer: Results of the phase II RTCMIENDOMETRE French multicentre trial","volume":"111","author":"Barillot","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2016.07.004_bib28","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/S0140-6736(09)62163-2","article-title":"Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): An open-label, non-inferiority, randomised trial","volume":"375","author":"Nout","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.ijrobp.2016.07.004_bib29","series-title":"Common terminology criteria for adverse events, version 3.0","year":"2003"},{"key":"10.1016\/j.ijrobp.2016.07.004_bib30","doi-asserted-by":"crossref","first-page":"428434","DOI":"10.1016\/j.ijrobp.2007.09.042","article-title":"Consensus guidelines for delineation of clinical target volume for intensity-modulated pelvic radiotherapy in postoperative treatment of endometrial and cervical cancer","volume":"71","author":"Small","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2016.07.004_bib31","unstructured":"Prescribing, recording, and reporting photon-beam intensity modulated radiotherapy (IMRT) Oxford: Oxford University Press, International Commission on Radiation Units and Measurements 2010; ICRU Report\u00a083."},{"key":"10.1016\/j.ijrobp.2016.07.004_bib32","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/S0360-3016(01)01820-X","article-title":"The dose-volume relationship of acute small bowel toxicity from concurrent 5-FU-based chemotherapy and radiation therapy for rectal cancer","volume":"52","author":"Baglan","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2016.07.004_bib33","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1177\/030089161209800407","article-title":"Daily on-line set-up correction in 3D-conformal radiotherapy: Is it feasible?","volume":"98","author":"Deodato","year":"2012","journal-title":"Tumori"},{"key":"10.1016\/j.ijrobp.2016.07.004_bib34","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.radonc.2008.07.009","article-title":"Complexity index (COMIX) and not type of treatment predicts undetected errors in radiotherapy planning and delivery","volume":"89","author":"Morganti","year":"2008","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2016.07.004_bib35","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Non-parametric estimation from incomplete observations","volume":"53","author":"Kaplan","year":"1985","journal-title":"J Am Statist Assoc"},{"key":"10.1016\/j.ijrobp.2016.07.004_bib36","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/0895-4356(94)90129-5","article-title":"Validation of a combined comorbidity index","volume":"47","author":"Charlson","year":"1994","journal-title":"J Clin Epidemiol"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301616328450?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301616328450?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,11]],"date-time":"2019-09-11T03:47:04Z","timestamp":1568173624000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301616328450"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["S0360301616328450"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2016.07.004","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Simultaneous Integrated Boost Volumetric Modulated Arc Therapy in the Postoperative Treatment of High-Risk to Intermediate-Risk Endometrial Cancer: Results of ADA II Phase 1-2 Trial","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2016.07.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}